Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : Lumo    crawled date : 2022 - 11 - 14    save search

Lumos Pharma Announces Encouraging Interim Results from Two Phase 2 Trials Evaluating Oral LUM-201 for Moderate Pediatric Growth Hormone Deficiency
Published: 2022-11-14 (Crawled : 12:00) - globenewswire.com
LUMO | $2.68 6.6K twitter stocktwits trandingview |
Health Technology
| | O: -0.45% H: 0.0% C: -34.39%

lum-201 pharma trials growth hormone
Lumos Pharma Reports Third Quarter 2022 Financial Results and Clinical Development Updates
Published: 2022-11-14 (Crawled : 12:00) - globenewswire.com
LUMO | $2.68 6.6K twitter stocktwits trandingview |
Health Technology
| | O: -0.45% H: 0.0% C: -34.39%

pharma financial results
Gainers vs Losers
87% 13%

Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M twitter stocktwits trandingview |

AGBA | $2.355 88.4% 34M twitter stocktwits trandingview |
Finance

CZOO | $9.32 86.77% 18M twitter stocktwits trandingview |

EDBL | News | $6.75 79.52% 1.5M twitter stocktwits trandingview |

MTC | $2.28 46.15% 2.6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.14 39.56% 7.6M twitter stocktwits trandingview |
Finance

VNRX | $0.8 33.33% 2.9M twitter stocktwits trandingview |
Health Technology

MLEC | $1.865 33.21% 2.4M twitter stocktwits trandingview |
n/a

PALI | $6.37 29.21% 21M twitter stocktwits trandingview |
Manufacturing

LOCL | $3.33 27.59% 43K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.